Share on LinkedInShare on LinkedIn

ARTICLE · 16 MAY 2024

Sklamberg Discusses Cannabis Rescheduling On NPR's 1A Podcast

Arnold & Porter
Arnold & Porter
Contributor
Arnold & Porter

Arnold & Porter

With over 1,000 lawyers across 16 offices worldwide, Arnold & Porter is renowned for its...

View firm profile
Explore more from Arnold & Porter

Howard Sklamberg, Life Sciences & Healthcare Regulatory partner and former FDA Deputy Commissioner, was recently a guest on NPR's podcast 1A for its episode...

United StatesCannabis & Hemp

Howard Sklamberg, Life Sciences & Healthcare Regulatory partner and former FDA Deputy Commissioner, was recently a guest on NPR's podcast 1A for its episode, "For the first time, the government is acknowledging marijuana's potential medical benefits." The episode discussed the recent move by Attorney General Merrick Garland to initiate the process of reclassifying cannabis as a Schedule III drug and what this change would mean for drug policy and cannabis research.

Listen to the full episode.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from